Covid: US gives full approval for antiviral remdesivir drug

Credit: BBC News- Published on October 22, 2020
The drug will be given to patients in hospitals, but the UN health agency says it has little effect.

Video credit: Reuters Studio
Published on October 23, 2020 -  01:29
Gilead's remdesivir gets U.S. FDA approval
The U.S. Food and Drug Administration on Thursday approved Gilead Sciences's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States. Gavino Garay reports.

You are here

💡 One News Page Knowledge: Other News Mentions

Coronavirus disease 2019

Disease caused by severe acute respiratory syndrome coronavirus 2
Minnesota Governor Tim Walz held a briefing Friday on the state's response to COVID-19, which has led to more than 3,800 reported deaths in the state. Officials..
Credit: CBS News - Published 28 minutes ago

"He died with COVID-19, and his final days were harder, scarier and lonelier than necessary," the obit said.
Credit: CBS News - Published 2 hours ago

In the video, the Holland pastor is seen coughing while delivering a sermon then telling the congregation to, "Get it, get it over with, press on."
Credit: - Published 2 hours ago

As U.S. deaths from COVID-19 topped 2,800 Thursday, a new daily high, and with more than 100,000 Americans hospitalized with the disease, VP Mike Pence is trying..
Credit: - Published 2 hours ago

Related videos from verified sources

FDA approves remdesivir as a treatment for COVID-19 patients in hospital 00:53
Credit: USA Today News (Domestic) - Published on October 23, 2020 

Related news from verified sources

US regulators have given full approval for the antiviral drug remdesivir to treat the Covid-19 patients in hospitals. The US Food and Drug Administration (FDA)...
on October 23, 2020 • Mid-Day

The U.S. Food and Drug Administration approved Gilead Sciences Inc.'s antiviral therapy remdesivir on Thursday, granting broad clearance for the coronavirus...
on October 22, 2020 • Newsmax

You might like